Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-053257
Filing Date
2019-10-16
Accepted
2019-10-16 14:41:50
Documents
1
Period of Report
2019-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6243
  Complete submission text file 0001209191-19-053257.txt   7906
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8090 Services-Misc Health & Allied Services, NEC

Mailing Address 20725 S. WESTERN AVE. SUITE 136 TORRANCE CA 90501
Business Address
LEE WILLIS C (Reporting) CIK: 0001517775 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35527 | Film No.: 191152641